Robert Clements

Robert Clements has over 30 years of international experience in the pharmaceuticals sector, and has held several senior roles in business development, commercial and marketing. He is an expert in market development for rare and chronic diseases.

Prior to becoming the chief commercial officer of MGC Pharmaceuticals in July 2022, Mr Clements was the vice president of business development of the international rare medicines division of Sciensus Rare, an international pharmaceutical services company based in the Netherlands, specialising in the provision of rare disease medicines.